阿卡波糖联合二甲双胍治疗2型糖尿病30例临床观察

2022-11-18 22:12:29 文档大全网 [ 字体：小中大 ] [ 阅读： ]

【#文档大全网# 导语】以下是®文档大全网的小编为您整理的《阿卡波糖联合二甲双胍治疗2型糖尿病30例临床观察》，欢迎阅读！
卡波,二甲,糖尿病,临床,观察
阿卡波糖联合二甲双胍治疗2型糖尿病30例临床观察

凌伟明

【期刊名称】《上海医药》【年(卷),期】2015(36)10

【摘要】目的:观察阿卡波糖联合二甲双胍治疗2型糖尿病的临床疗效和不良反应.方法:选择2014年4月至5月南京西路社区卫生服务中心门诊的2型糖尿病患者60例,分为观察组和对照组各30例.观察组给予阿卡波糖和二甲双胍治疗,对照组维持单品种降糖药治疗.3个月后比较两组的治疗效果.结果:观察组总有效率为83.3%(25/30),对照组为53.3%(16/30),两组比较差异有统计学意义

(χ2=4.93,P<0.05).两组不良反应差异无统计学意义(χ2=0.14, P>0.05).结论:阿卡波糖联合二甲双胍可以作为基层医院治疗2型糖尿病的选择.%Objective: To observe the clinical efifcacy and adverse reaction of acarbose combined with metformin in the treatment of type 2 diabetes.Methods:Sixty cases of type 2 diabetes were selected in Nanjing West Road Community Health Service Center from April to Mary 2014, and divided into an observation group and a control group with 30 cases each. The observation group received the treatment of acarbose and metformin, and the control group maintained a single hypoglycemic treatment. The treatment effect between two groups was compared after 3 months.Results: The total effective rate was 83.3%(25/30) in the observation group and

53.3%(16/30)in the control one, and the comparison difference between two groups had the statistical signiifcance (χ2=4.93,P<0.05). The difference

of the adverse reaction between two groups had no signiifcant difference (χ2=0.14,P>0.05).Conclusion: Acarbose combined with metformin can be used as a grass-roots hospital choice for the treatment of type 2 diabetes. 【总页数】2页(P29-30) 【作者】凌伟明

【作者单位】上海市静安区南京西路街道社区卫生服务中心上海200041 【正文语种】中文【中图分类】R587.1 【相关文献】

1.二甲双胍联合二肽基肽酶-Ⅳ抑制剂及阿卡波糖治疗2型糖尿病的临床观察 [J], 陈翠环;冯燕

2.二甲双胍联合阿卡波糖治疗2型糖尿病的临床观察 [J], 葛津津 3.二甲双胍联合阿卡波糖治疗2型糖尿病的临床观察 [J], 王勇刚 4.二甲双胍联合阿卡波糖治疗2型糖尿病的临床观察 [J], 王君平 5.阿卡波糖联合二甲双胍治疗新发肥胖2型糖尿病临床观察 [J], 胡晓丽

因版权原因，仅展示原文概要，查看原文内容请购买